AT1受容体拮抗薬の世界市場動向・分析2018-2025

【英語タイトル】Global AT1 Receptor Antagonists Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D00613)・商品コード:QYR8D00613
・発行会社(調査会社):QYResearch
・発行日:2018年10月31日(※2024年版があります。お問い合わせください)
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、AT1受容体拮抗薬の世界市場について調査・分析し、種類別には、バルサルタン、テルミサルタン、ロサルタン、イルベサルタン、アジルサルタン、オルメサルタンに、用途別には、高血圧、心血管病気、腎臓病、その他に区分してまとめました。調査対象企業は、Pfizer、Novartis、Merck、Astra Zeneca、Jhonson and Johnson、Eli Lilly and Company、Sanofi SA、Bristol-Myers Squibb、Bayer、GSK、Teva Pharmaceutical等です。

・レポートの概要
・グローバル成長トレンド
・AT1受容体拮抗薬の世界市場規模
・AT1受容体拮抗薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別AT1受容体拮抗薬の価格動向
・AT1受容体拮抗薬の種類別市場規模(バルサルタン、テルミサルタン、ロサルタン、イルベサルタン、アジルサルタン、オルメサルタン)
・AT1受容体拮抗薬の用途別市場規模(高血圧、心血管病気、腎臓病、その他)
・AT1受容体拮抗薬の北米市場(アメリカ、カナダ、メキシコ)
・AT1受容体拮抗薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・AT1受容体拮抗薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・AT1受容体拮抗薬の中南米市場(ブラジル等)
・AT1受容体拮抗薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Pfizer、Novartis、Merck、Astra Zeneca、Jhonson and Johnson、Eli Lilly and Company、Sanofi SA、Bristol-Myers Squibb、Bayer、GSK、Teva Pharmaceutical)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・AT1受容体拮抗薬の市場規模予測
・AT1受容体拮抗薬の種類別市場予測2018-2025(バルサルタン、テルミサルタン、ロサルタン、イルベサルタン、アジルサルタン、オルメサルタン)
・AT1受容体拮抗薬の用途別市場予測2018-2025(高血圧、心血管病気、腎臓病、その他)
・AT1受容体拮抗薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・AT1受容体拮抗薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・AT1受容体拮抗薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・AT1受容体拮抗薬の中南米市場予測2018-2025(ブラジル等)
・AT1受容体拮抗薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

AT1 receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.In 2018, the global AT1 Receptor Antagonists market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for AT1 Receptor Antagonists.

This study researches the market size of AT1 Receptor Antagonists, presents the global AT1 Receptor Antagonists sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of AT1 Receptor Antagonists in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of AT1 Receptor Antagonists for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly and Company
Sanofi SA
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Market Segment by Product Type
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan

Market Segment by Application
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global AT1 Receptor Antagonists status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key AT1 Receptor Antagonists manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of AT1 Receptor Antagonists are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Type
1.3.2 Valsartan
1.3.3 Telmisartan
1.3.4 Losartan
1.3.5 Irbesartan
1.3.6 Azilsartan
1.3.7 Olmesartan
1.4 Market Segment by Application
1.4.1 Global AT1 Receptor Antagonists Market Share by Application (2018-2025)
1.4.2 Hypertension
1.4.3 Cardiovascular Diseases
1.4.4 Kidney Diseases
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global AT1 Receptor Antagonists Market Size
2.1.1 Global AT1 Receptor Antagonists Revenue 2013-2025
2.1.2 Global AT1 Receptor Antagonists Sales 2013-2025
2.2 AT1 Receptor Antagonists Growth Rate by Regions
2.2.1 Global AT1 Receptor Antagonists Sales by Regions 2013-2018
2.2.2 Global AT1 Receptor Antagonists Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 AT1 Receptor Antagonists Sales by Manufacturers
3.1.1 AT1 Receptor Antagonists Sales by Manufacturers 2013-2018
3.1.2 AT1 Receptor Antagonists Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 AT1 Receptor Antagonists Revenue by Manufacturers (2013-2018)
3.2.2 AT1 Receptor Antagonists Revenue Share by Manufacturers (2013-2018)
3.2.3 Global AT1 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.3 AT1 Receptor Antagonists Price by Manufacturers
3.4 Key Manufacturers AT1 Receptor Antagonists Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into AT1 Receptor Antagonists Market
3.6 Key Manufacturers AT1 Receptor Antagonists Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Valsartan Sales and Revenue (2013-2018)
4.1.2 Telmisartan Sales and Revenue (2013-2018)
4.1.3 Losartan Sales and Revenue (2013-2018)
4.1.4 Irbesartan Sales and Revenue (2013-2018)
4.1.5 Azilsartan Sales and Revenue (2013-2018)
4.1.6 Olmesartan Sales and Revenue (2013-2018)
4.2 Global AT1 Receptor Antagonists Sales Market Share by Type
4.3 Global AT1 Receptor Antagonists Revenue Market Share by Type
4.4 AT1 Receptor Antagonists Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global AT1 Receptor Antagonists Sales by Application

6 North America
6.1 North America AT1 Receptor Antagonists Breakdown Data by Company
6.2 North America AT1 Receptor Antagonists Breakdown Data by Type
6.3 North America AT1 Receptor Antagonists Breakdown Data by Application
6.4 North America AT1 Receptor Antagonists Breakdown Data by Countries
6.4.1 North America AT1 Receptor Antagonists Sales by Countries
6.4.2 North America AT1 Receptor Antagonists Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe AT1 Receptor Antagonists Breakdown Data by Company
7.2 Europe AT1 Receptor Antagonists Breakdown Data by Type
7.3 Europe AT1 Receptor Antagonists Breakdown Data by Application
7.4 Europe AT1 Receptor Antagonists Breakdown Data by Countries
7.4.1 Europe AT1 Receptor Antagonists Sales by Countries
7.4.2 Europe AT1 Receptor Antagonists Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific AT1 Receptor Antagonists Breakdown Data by Company
8.2 Asia Pacific AT1 Receptor Antagonists Breakdown Data by Type
8.3 Asia Pacific AT1 Receptor Antagonists Breakdown Data by Application
8.4 Asia Pacific AT1 Receptor Antagonists Breakdown Data by Countries
8.4.1 Asia Pacific AT1 Receptor Antagonists Sales by Countries
8.4.2 Asia Pacific AT1 Receptor Antagonists Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America AT1 Receptor Antagonists Breakdown Data by Company
9.2 Central & South America AT1 Receptor Antagonists Breakdown Data by Type
9.3 Central & South America AT1 Receptor Antagonists Breakdown Data by Application
9.4 Central & South America AT1 Receptor Antagonists Breakdown Data by Countries
9.4.1 Central & South America AT1 Receptor Antagonists Sales by Countries
9.4.2 Central & South America AT1 Receptor Antagonists Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa AT1 Receptor Antagonists Breakdown Data by Type
10.2 Middle East and Africa AT1 Receptor Antagonists Breakdown Data by Application
10.3 Middle East and Africa AT1 Receptor Antagonists Breakdown Data by Countries
10.3.1 Middle East and Africa AT1 Receptor Antagonists Sales by Countries
10.3.2 Middle East and Africa AT1 Receptor Antagonists Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.1.4 AT1 Receptor Antagonists Product Introduction
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.2.4 AT1 Receptor Antagonists Product Introduction
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.3.4 AT1 Receptor Antagonists Product Introduction
11.3.5 Merck Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.4.4 AT1 Receptor Antagonists Product Introduction
11.4.5 Astra Zeneca Recent Development
11.5 Jhonson and Johnson
11.5.1 Jhonson and Johnson Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.5.4 AT1 Receptor Antagonists Product Introduction
11.5.5 Jhonson and Johnson Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.6.4 AT1 Receptor Antagonists Product Introduction
11.6.5 Eli Lilly and Company Recent Development
11.7 Sanofi SA
11.7.1 Sanofi SA Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.7.4 AT1 Receptor Antagonists Product Introduction
11.7.5 Sanofi SA Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.8.4 AT1 Receptor Antagonists Product Introduction
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.9.4 AT1 Receptor Antagonists Product Introduction
11.9.5 Bayer Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.10.4 AT1 Receptor Antagonists Product Introduction
11.10.5 GSK Recent Development
11.11 Teva Pharmaceutical

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 AT1 Receptor Antagonists Sales Channels
12.2.2 AT1 Receptor Antagonists Distributors
12.3 AT1 Receptor Antagonists Customers

13 Market Forecast
13.1 Global AT1 Receptor Antagonists Sales and Revenue Forecast 2018-2025
13.2 Global AT1 Receptor Antagonists Sales Forecast by Type
13.3 Global AT1 Receptor Antagonists Sales Forecast by Application
13.4 AT1 Receptor Antagonists Forecast by Regions
13.4.1 Global AT1 Receptor Antagonists Sales Forecast by Regions 2018-2025
13.4.2 Global AT1 Receptor Antagonists Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America AT1 Receptor Antagonists Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe AT1 Receptor Antagonists Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure AT1 Receptor Antagonists Product Picture
Table AT1 Receptor Antagonists Key Market Segments
Table Major Manufacturers AT1 Receptor Antagonists Covered in This Report
Table Global AT1 Receptor Antagonists Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global AT1 Receptor Antagonists Sales Market Shar by Type 2013-2025
Figure Valsartan Figures
Table Major Manufacturers of Valsartan
Figure Telmisartan Figures
Table Major Manufacturers of Telmisartan
Figure Losartan Figures
Table Major Manufacturers of Losartan
Figure Irbesartan Figures
Table Major Manufacturers of Irbesartan
Figure Azilsartan Figures
Table Major Manufacturers of Azilsartan
Figure Olmesartan Figures
Table Major Manufacturers of Olmesartan
Table Global AT1 Receptor Antagonists Market Share by Application 2018-2025 (K Units)
Figure Hypertension Use Case
Figure Cardiovascular Diseases Use Case
Figure Kidney Diseases Use Case
Figure Other Use Case
Figure AT1 Receptor Antagonists Report Years Considered
Figure Global AT1 Receptor Antagonists Market Size 2013-2025 (Million US$)
Figure Global AT1 Receptor Antagonists Sales 2013-2018 (K Units)
Table Global AT1 Receptor Antagonists Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global AT1 Receptor Antagonists Sales by Regions 2013-2018 (K Units)
Table Global AT1 Receptor Antagonists Sales Market Share by Regions 2013-2018
Figure Global AT1 Receptor Antagonists Sales Market Share by Regions 2013-2018
Figure Global AT1 Receptor Antagonists Sales Market Share by Regions in 2018
Table Global AT1 Receptor Antagonists Revenue by Regions 2013-2018 (Million US$)
Table Global AT1 Receptor Antagonists Revenue Market Share by Regions 2013-2018
Figure Global AT1 Receptor Antagonists Revenue Market Share by Regions 2013-2018
Figure Global AT1 Receptor Antagonists Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global AT1 Receptor Antagonists Sales by Manufacturers (2013-2018) (K Units)
Table Global AT1 Receptor Antagonists Sales Share by Manufacturers (2013-2018)
Figure Global AT1 Receptor Antagonists Sales Share by Manufacturers in 2018
Table AT1 Receptor Antagonists Revenue by Manufacturers (2013-2018) (Million USD)
Table AT1 Receptor Antagonists Revenue Share by Manufacturers (2013-2018)
Figure AT1 Receptor Antagonists Value Share by Manufacturers in 2018
Table Global AT1 Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers AT1 Receptor Antagonists Price (2013-2018) (USD/Unit)
Table Key Manufacturers AT1 Receptor Antagonists Plants/Factories Distribution
Table Key Manufacturers AT1 Receptor Antagonists Area Served
Table Date of Key Manufacturers Enter into AT1 Receptor Antagonists Market
Table Key Manufacturers AT1 Receptor Antagonists Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Valsartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Telmisartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Losartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Irbesartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Azilsartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Olmesartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Global AT1 Receptor Antagonists Sales Share by Type (2013-2018)
Figure Global AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure Global AT1 Receptor Antagonists Sales Market Share by Type in 2017
Table Global AT1 Receptor Antagonists Revenue by Type (2013-2018) (Million US$)
Table Global AT1 Receptor Antagonists Revenue Share by Type (2013-2018)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Type (2013-2018)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Type in 2017
Table AT1 Receptor Antagonists Price by Type 2013-2018 (USD/Unit)
Table Global AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Global AT1 Receptor Antagonists Sales Share by Application (2013-2018)
Figure Global Sales AT1 Receptor Antagonists Market Share by Application (2013-2018)
Figure Global Sales AT1 Receptor Antagonists Market Share by Application in 2017
Figure North America AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure North America AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table North America AT1 Receptor Antagonists Sales by Company (2013-2018) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Company (2013-2018)
Figure North America AT1 Receptor Antagonists Sales Market Share by Company in 2018
Table North America AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure North America AT1 Receptor Antagonists Market Share by Type in 2018
Table North America AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure North America AT1 Receptor Antagonists Market Share by Application in 2018
Table North America AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure 2017 North America AT1 Receptor Antagonists Sales Market Share by Countries
Table North America AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table North America AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure 2017 North America AT1 Receptor Antagonists Revenue Market Share by Countries
Figure United States AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Canada AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Mexico AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Europe AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure Europe AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table Europe AT1 Receptor Antagonists Sales by Company (2013-2018) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Company (2013-2018)
Figure Europe AT1 Receptor Antagonists Sales Market Share by Company in 2018
Table Europe AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure 2017 Europe AT1 Receptor Antagonists Market Share by Type
Table Europe AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure 2017 Europe AT1 Receptor Antagonists Market Share by Application
Table Europe AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure 2017 Europe AT1 Receptor Antagonists Sales Market Share by Countries
Table Europe AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table Europe AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure Europe AT1 Receptor Antagonists Revenue Market Share by Countries in 2018
Figure Germany AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure France AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure UK AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Italy AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Russia AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific AT1 Receptor Antagonists Sales by Company (2013-2018) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Company (2013-2018)
Figure Asia Pacific AT1 Receptor Antagonists Sales Market Share by Company in 2018
Table Asia Pacific AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure Asia Pacific AT1 Receptor Antagonists Market Share by Type in 2018
Table Asia Pacific AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure Asia Pacific AT1 Receptor Antagonists Market Share by Application in 2018
Table Asia Pacific AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific AT1 Receptor Antagonists Sales Market Share by Countries
Table Asia Pacific AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Countries
Figure China AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure China AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Japan AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Korea AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure India AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure India AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Australia AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Philippines AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Thailand AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America AT1 Receptor Antagonists Sales by Company (2013-2018) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Company (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Sales Market Share by Company in 2018
Table Central & South America AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Market Share by Type in 2018
Table Central & South America AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Market Share by Application in 2018
Table Central & South America AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Sales Market Share by Countries in 2018
Table Central & South America AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table Central & South America AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Revenue Market Share by Countries in 2018
Figure Brazil AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Brazil AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Market Share by Type
Table Middle East and Africa AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Market Share by Application
Table Middle East and Africa AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries
Table Middle East and Africa AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries
Figure GCC Countries AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Egypt AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure South Africa AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (K Units)
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Pfizer AT1 Receptor Antagonists Sales Market Share in Global Market
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novartis AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Novartis AT1 Receptor Antagonists Sales Market Share in Global Market
Table Novartis Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Merck AT1 Receptor Antagonists Sales Market Share in Global Market
Table Merck Recent Development
Table Astra Zeneca Company Details
Table Astra Zeneca Description and Business Overview
Table Astra Zeneca AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Astra Zeneca AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Astra Zeneca AT1 Receptor Antagonists Sales Market Share in Global Market
Table Astra Zeneca Recent Development
Table Jhonson and Johnson Company Details
Table Jhonson and Johnson Description and Business Overview
Table Jhonson and Johnson AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Jhonson and Johnson AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Jhonson and Johnson AT1 Receptor Antagonists Sales Market Share in Global Market
Table Jhonson and Johnson Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Description and Business Overview
Table Eli Lilly and Company AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Eli Lilly and Company AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Eli Lilly and Company AT1 Receptor Antagonists Sales Market Share in Global Market
Table Eli Lilly and Company Recent Development
Table Sanofi SA Company Details
Table Sanofi SA Description and Business Overview
Table Sanofi SA AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sanofi SA AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Sanofi SA AT1 Receptor Antagonists Sales Market Share in Global Market
Table Sanofi SA Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Description and Business Overview
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales Market Share in Global Market
Table Bristol-Myers Squibb Recent Development
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Bayer AT1 Receptor Antagonists Sales Market Share in Global Market
Table Bayer Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table GSK AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table GSK AT1 Receptor Antagonists Sales Market Share in Global Market
Table GSK Recent Development
Table Teva Pharmaceutical Company Details
Figure AT1 Receptor Antagonists Value Chain
Table AT1 Receptor Antagonists Distributors List
Table AT1 Receptor Antagonists Customers List
Table Global AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Revenue Forecast 2018-2025 (Million US$)
Table Global AT1 Receptor Antagonists Sales Forecast by Type 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Forecast by Type 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Market Share Forecast by Type 2018-2025
Table Global AT1 Receptor Antagonists Sales Forecast by Application 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Forecast by Application 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Market Share Forecast by Application 2018-2025
Table Global AT1 Receptor Antagonists Sales Forecast by Regions 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Forecast by Regions 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Market Share Forecast by Regions 2018-2025
Table Global AT1 Receptor Antagonists Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global AT1 Receptor Antagonists Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global AT1 Receptor Antagonists Revenue Market Share Forecast by Regions 2018-2025
Table North America AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025 (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share Forecast by Countries 2018-2025
Table North America AT1 Receptor Antagonists Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America AT1 Receptor Antagonists Revenue Market Share Forecast by Countries 2018-2025
Figure United States AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Canada AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure MexicoAT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Table Europe AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025 (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share Forecast by Countries 2018-2025
Table Europe AT1 Receptor Antagonists Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe AT1 Receptor Antagonists Revenue Market Share Forecast by Countries 2018-2025
Figure Germany AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure France AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure UK AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Italy AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Russia AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific AT1 Receptor Antagonists Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific AT1 Receptor Antagonists Revenue Market Share Forecast by Countries 2018-2025
Figure China AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Japan AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Korea AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure India AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Australia AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Indonesia AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Thailand AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Malaysia AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Philippines AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Vietnam AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share Forecast by Countries 2018-2025
Table Central & South America AT1 Receptor Antagonists Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America AT1 Receptor Antagonists Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa AT1 Receptor Antagonists Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa AT1 Receptor Antagonists Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Egypt AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure South Africa AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Pfizer、Novartis、Merck、Astra Zeneca、Jhonson and Johnson、Eli Lilly and Company、Sanofi SA、Bristol-Myers Squibb、Bayer、GSK、Teva Pharmaceutical

★調査レポート[AT1受容体拮抗薬の世界市場動向・分析2018-2025] (コード:QYR8D00613)販売に関する免責事項を必ずご確認ください。
★調査レポート[AT1受容体拮抗薬の世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆